Get startedLog in
    Picture of SIGA Technologies logo

    SIGA — SIGA Technologies News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapFalling Star
    All News

    Pharma firm SIGA Q2 product revenues rise

    Picture of SIGA Technologies logoSIGA Technologies
    05/08/2025 21:09
    Overview

SIGA Q2 product revenues rise to $79 mln, driven by TPOXX sales

Company awarded $27 mln in BARDA 19C contract funding for development

Net income for Q2 jumps to $35.5 mln, reflecting strong performance

Result Drivers

TPOXX SALES - $53 mln from oral TPOXX and $26 mln from IV TPOXX sales to Strategic National Stockpile

BARDA FUNDING - $27 mln awarded for TPOXX pediatric program and manufacturing support under BARDA 19C contract

Key Details


    MetricBeat/MissActualConsensus Estimate
    Q2 EPS$0.49
    Q2 Net Income$35.50 mln
    

Analyst Coverage

The stock recently traded at 6 times the next 12-month earnings vs. a P/E of 5 three months ago

Press Release: ID:nGNX7jGW8k

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

    Recent news on SIGA Technologies

    See all news